complement
system
import
part
innat
immun
play
critic
role
pathogen
clearanc
unregul
complement
activ
like
play
crucial
role
pathogenesi
acut
lung
injuri
ali
induc
highli
pathogen
viru
includ
influenza
virus
sever
acut
respiratori
syndrom
sar
coronaviru
highli
pathogen
virusinduc
acut
lung
diseas
high
level
chemotact
anaphylatox
produc
result
excess
complement
activaiton
overproduc
display
power
biolog
activ
activ
phagocyt
cell
gener
oxid
inflammatori
sequela
name
cytokin
storm
blockad
signal
implic
treatment
ali
induc
highli
pathogen
viru
herein
review
literatur
link
ali
review
understand
mechan
affect
ali
highli
pathogen
viral
infect
particular
discuss
potenti
blockad
signal
treat
ali
induc
highli
pathogen
virus
epithelium
lung
vulner
damag
caus
inhal
microorgan
noxiou
particl
mani
studi
suggest
presenc
complement
compon
alveolar
epithelium
inhal
airborn
particl
microorgan
deposit
addit
complement
system
implic
develop
acut
lung
diseas
induc
highli
pathogen
virus
includ
influenza
viru
sever
acut
respiratori
syndrom
coronaviru
sarscov
middl
east
respiratori
syndrom
coronaviru
merscov
howev
specif
contribut
complement
lung
diseas
base
innat
adapt
immun
begin
emerg
elucid
role
complementmedi
immun
regul
diseas
help
identifi
new
target
therapeut
intervent
complement
activ
lead
format
bioactiv
molecul
includ
anaphylatoxin
lytic
membran
attack
complex
complementactiv
product
strong
chemoattract
involv
recruit
inflammatori
cell
neutrophil
eosinophil
monocyt
lymphocyt
activ
phagocyt
cell
releas
granulebas
enzym
gener
oxid
also
display
power
biolog
activ
includ
induc
cytokin
storm
hand
blockad
signal
demonstr
potenti
benefit
treatment
acut
lung
injuri
ali
induc
highli
pathogen
virus
articl
summar
recent
develop
understand
role
mediat
aut
lung
injuri
induc
highli
pathogen
virus
highli
pathogen
viru
due
high
mutat
rate
virus
everi
sever
year
decad
highli
pathogen
viru
emerg
especi
recent
decad
five
highli
pathogen
virus
sar
coronaviru
avian
influenza
viru
viru
viru
mer
coronaviru
exemplifi
coronavirus
influenza
virus
bat
bird
natur
reservoir
provid
viral
gene
evolut
new
viru
speci
virus
interspeci
transmiss
primari
caus
outbreak
jump
directli
bird
human
two
month
laboratoryconfirm
case
death
report
global
vaccin
human
use
current
sar
mer
vaccin
avail
current
vaccin
strategi
still
inadequ
provid
protect
epidem
outbreak
thu
urgent
explor
mechan
highli
pathogen
virus
induc
diseas
acut
lung
injuri
induc
highli
pathogen
viral
infect
although
highli
pathogen
viru
infect
differ
epidemiolog
similar
rapid
progress
acut
respiratori
distress
syndrom
ard
exampl
histopatholog
chang
lung
patient
infect
highli
similar
patient
sar
except
influenza
viru
avian
influenza
viru
also
caus
sever
pneumonia
postmortem
biopsi
patient
infect
show
acut
diffus
alveolar
damag
patient
die
day
symptom
onset
intraalveolar
hemorrhag
wherea
patient
die
day
symptom
onset
pulmonari
fibro
prolif
chang
patient
infect
develop
rapidli
progress
pneumonia
result
ali
ard
ali
may
critic
caus
death
patient
infect
like
infect
also
caus
seriou
lung
patholog
addit
sarscov
infect
caus
ali
may
progress
lifethreaten
ard
merscov
infect
result
sever
pneumonia
sarscov
infect
respiratori
distress
common
caus
death
patient
infect
highli
pathogen
viru
term
therapi
lung
protect
ventil
cornerston
support
care
extracorpor
membran
oxygen
routin
use
mani
center
treatment
sever
respiratori
tract
infect
howev
due
effect
treatment
option
ali
often
fatal
patient
infect
highli
pathogen
virus
suggest
seriou
lung
patholog
particular
concern
microorgan
infect
begin
host
quickli
activ
complement
system
clear
infect
pathogen
complement
activ
high
level
product
commonli
involv
exacerb
inflammatori
reaction
caus
direct
harm
host
follow
infect
iav
belong
orthomyxovirida
famili
singlestrand
negativesens
rna
viru
capac
activ
complement
system
addit
avian
influenza
hemagglutinin
typic
bind
alpha
sialic
acid
receptor
wherea
human
influenza
hemagglutinin
bind
alpha
sialic
acid
receptor
thu
replic
lower
respiratori
tract
caus
complement
activ
suggest
upon
influenza
infect
high
level
includ
fragment
produc
complement
activ
possibl
contribut
observ
tissu
damag
sever
viral
infect
studi
demonstr
ali
mice
caus
excess
complement
activ
releas
thu
complement
activ
play
critic
role
pathogenesi
virusinduc
acut
lung
injuri
among
complement
activ
product
anaphylatoxin
one
potent
inflammatori
peptid
increas
level
found
bronchoalveolar
lavag
fluid
balf
serum
patient
infect
fatal
pandem
viru
also
found
increas
balf
mice
infect
highli
pathogen
avian
influenza
follow
season
iav
infect
hand
balf
recov
patient
ard
demonstr
significantli
reduc
chemotact
activ
thu
might
play
critic
role
pathogenesi
virusinduc
acut
lung
injuri
inflammatori
cell
migrat
lung
tissu
compar
normal
control
sar
patient
increas
cellular
balf
increas
alveolar
macrophag
thu
mononuclear
cell
infiltr
might
import
role
pathogenesi
ali
induc
highli
pathogen
virus
like
sar
anaphylatoxin
implic
pathogenesi
ard
mediat
neutrophil
attract
aggreg
activ
subsequ
pulmonari
endotheli
damag
revers
chemotact
activ
significantli
decreas
recov
patient
ard
suggest
mobil
activ
immun
cell
might
central
event
tissu
injuri
caus
highli
pathogen
viral
infect
two
chemoattract
interleukin
synthes
cell
lung
eg
macrophag
epitheli
cell
endotheli
cell
smooth
muscl
cell
neutrophil
level
also
found
correl
neutrophil
number
degre
lung
dysfunct
could
strongli
amplifi
express
human
whole
blood
cell
induc
lipopolysaccharid
type
tolllik
receptor
agonist
via
extracellularsignalregul
kinas
cjun
ntermin
kinas
data
suggest
might
critic
effector
molecul
mediat
lymphocyt
attract
indirectli
enhanc
product
altogeth
lymphocyt
attract
play
critic
role
pathogenesi
ali
induc
highli
pathogen
virus
neutrophil
extracellular
trap
net
primarili
compos
dna
neutrophil
bind
pathogen
antimicrobi
protein
net
benefici
antimicrobi
defens
help
fight
invad
pathogen
howev
excess
net
contribut
patholog
number
diseas
includ
lung
net
found
infectionrel
ali
model
influenza
viru
vitro
studi
demonstr
associ
granulocytemacrophag
colonystimul
factor
abl
induc
releas
net
also
abl
activ
macrophag
endotheli
cell
promot
vascular
leakag
releas
net
thu
net
induc
iav
infect
associ
alveolar
damag
iavinduc
pneumon
excess
net
compon
potent
factor
lung
injuri
net
increas
permeabl
alveolarcapillari
barrier
cleav
endotheli
actin
cytoskeleton
ecadherin
vecadherin
antimicrobi
peptid
net
structur
present
cytotox
proapoptot
properti
toward
endotheli
epitheli
cell
net
also
induc
releas
proinflammatori
cytokin
data
suggest
neutrophil
extracellular
trap
aggrav
ali
patient
infect
highli
pathogen
viru
releas
reactiv
oxygen
speci
strong
chemoattract
neutrophil
monocyt
activ
cell
gener
oxid
burst
releas
studi
demonstr
ro
primari
pathogen
molecul
pneumonia
mice
infect
influenza
viru
amount
durat
exposur
gener
ro
releas
respiratori
immun
inflammatori
cell
determin
extent
lung
damag
lung
fibros
inflammatori
cell
produc
significantli
greater
amount
ro
critic
antioxid
treatment
significantli
reduc
lung
damag
mortal
influenzainfect
mice
studi
demonstr
critic
role
reactiv
oxygen
intermedi
roi
virusinduc
epitheli
damag
interact
play
critic
role
oxid
burst
intercept
signal
antagonist
significantli
inhibit
oxid
burst
neutrophil
induc
e
coli
similarli
block
oxid
burst
whole
blood
induc
neisseria
meningitid
phosphoryl
phox
essenti
assembl
nadph
oxidas
subsequ
product
h
strong
activ
mitogenactiv
protein
kinas
includ
import
kinas
phox
phosphoryl
except
directli
affect
tissu
damag
oxid
product
might
also
involv
signal
transduct
pathway
express
enhanc
oxid
sensit
transcript
factor
nuclear
factorkb
activ
lung
influenzainfect
mice
mean
oxygenderiv
free
radic
might
exert
much
greater
effect
pathogenesi
diseas
indirectli
induc
proinflammatori
mediat
thu
oxygenderiv
free
radic
thought
import
event
pathogenesi
diseas
releas
histon
histon
essenti
regul
genom
function
eukaryot
cell
protein
influenza
subtyp
possess
histonelik
sequenc
histon
mimic
could
target
human
rna
polymeraseassoci
factor
transcript
elong
complex
crucial
role
antivir
respons
thu
viru
use
histon
mimic
suppress
human
rna
polymeraseassoci
factor
transcript
elong
complexmedi
antivir
respons
divers
modifi
histon
regul
gene
replic
repair
transcript
activ
influenza
reduc
associ
interferon
ifni
ifniii
promot
dendrit
cell
dc
suppress
antivir
gene
express
contrast
ifn
associ
tumor
necrosi
factora
tnfa
promot
disturb
histon
excret
cell
reduc
intracellular
histon
suppress
antivir
gene
express
set
ali
human
mice
histon
presenc
found
balf
addit
polymorphonuclear
leukocyt
incub
vitro
vivo
neutrophil
extracellular
histonescontain
extracellular
trap
net
develop
result
suggest
engag
receptor
led
appear
extracellular
histon
balf
extracellular
histon
significantli
enhanc
inflammatori
respons
induc
nucleotidebind
domain
leucinerich
repeat
contain
famili
pyrin
domain
contain
inflammasom
furthermor
airway
instil
histon
result
intens
lung
injuri
inflamm
togeth
fibrin
clot
pulmonari
vein
releas
histon
import
contribut
pathogenesi
ali
process
leukocyt
adhes
endotheli
cell
first
critic
step
neutrophil
migrat
area
inflamm
adhes
molecul
surfac
endotheli
cell
import
role
inflammatori
cell
migrat
fact
regul
express
adhes
molecul
directli
activ
endotheli
cell
upregul
adhes
molecul
pselectin
addit
tnfa
cooper
enhanc
upregul
intercellular
adhes
molecul
eselectin
thu
effect
mediat
first
step
inflammatori
cell
migrat
lung
adhes
molecul
surfac
inflammatori
cell
also
import
role
inflammatori
cell
migrat
vitro
studi
demonstr
upregul
express
neutrophil
induc
addit
also
induc
express
integrin
blood
neutrophil
thu
enhanc
adhes
interact
neutrophil
endotheli
cell
promot
inflammatori
cell
migrat
inflammatori
site
adhes
molecul
effect
enhanc
proinflammatori
cytokin
tnfa
product
pulmonari
macrophag
turn
promot
inflammatori
respons
blockad
cdllb
intercellular
adhes
molecul
pselectin
significantli
reduc
ali
damag
neutrophil
content
lung
might
protect
tissu
injuri
variou
organ
limit
neutrophil
sequestr
downregul
express
adhes
molecul
studi
suggest
upregul
adhes
molecul
promot
inflammatori
respons
adapt
immun
respons
induc
innat
immun
cell
includ
mast
cell
neutrophil
macrophag
releas
cytokin
tnfa
macrophag
inflammatori
strong
activ
cell
wherea
tnfa
promot
transendotheli
migrat
cell
upregul
vascular
adhes
molecul
induc
ifnc
express
cell
data
demonstr
indirectli
induc
adapt
immun
respons
activ
innat
immun
cell
apart
innat
immun
cell
human
dc
cell
also
express
receptor
thu
also
potent
chemoattract
human
cell
b
cell
dc
addit
earli
inflammatori
stage
pathogen
infect
dc
use
home
signal
take
ag
prime
help
tcell
function
thu
induc
adapt
immun
respons
recruit
dc
cell
import
signal
tcell
prolifer
differenti
induc
interact
locallyproduc
antigenpres
cell
apc
accordingli
could
activ
apc
induc
cell
activ
data
suggest
local
interact
apc
critic
cell
prolifer
differenti
bind
also
play
import
role
cell
respons
cell
activ
influenza
infect
requir
act
chemoattract
lymphocyt
thu
conceiv
might
elicit
cell
respons
upon
input
stimuli
accordingli
antagonist
reduc
frequenc
absolut
number
fluspecif
cell
patient
infect
influenza
viru
like
inflammatori
cytokin
play
major
role
mediat
amplifi
ali
ard
stimul
chemotaxi
induc
innat
immun
cell
includ
mast
cell
neutrophil
monocytesmacrophag
releas
proinflammatori
cytokin
tnfa
macrophag
inflammatori
addit
also
stimul
adapt
immun
cell
b
cell
releas
cytokin
tnfa
mani
cytokin
trigger
highli
pathogen
virus
like
call
cytokin
storm
cytokin
rapidli
induc
post
infect
proinflammatori
cytokin
includ
tnfa
might
contribut
sever
diseas
promot
maxim
lung
inflamm
caus
viral
infect
compar
healthi
volunt
patient
significantli
higher
level
cytokin
ifncinduc
protein
ifnc
tnfa
danger
cytokin
storm
also
occur
sar
repres
sarscov
ssrna
power
immunostimulatori
activ
induc
proinflammatori
cytokin
tnfa
elev
level
proinflammatori
cytokin
includ
moncyt
chemoattract
transform
growth
tnfa
produc
cell
infect
sarscov
might
caus
ali
addit
cytokin
could
induc
cytokin
enhanc
proinflammatori
respons
take
exampl
elev
level
tnfa
induc
cytokin
like
thu
cytokin
storm
play
import
role
ali
antitnfa
etanercept
significantli
reduc
damag
ali
inhibit
macrophag
migrat
inhibitori
factor
allevi
influenza
viru
pneumonia
murin
model
caus
signific
reduct
pulmonari
inflammatori
cytokin
tnfa
ifncinduc
protein
wide
use
antivir
agent
arbidol
hydrochlorid
effici
inhibit
strain
diminish
viral
replic
acut
inflamm
suppress
inflammatori
cytokin
tnfa
studi
indic
blockad
cytokin
storm
effect
treatment
infect
highli
pathogen
viru
sever
patient
state
immun
paralysi
gener
leukopenia
low
antigenpres
capac
impair
cell
respons
suffer
fatal
infect
particularli
low
proport
peripher
blood
lymphocyt
subgroup
previou
studi
demonstr
induc
thymocyt
apoptosi
turn
result
decreas
number
cell
circul
attend
immunosuppress
suggest
strike
contrast
neutrophil
thymocyt
appar
receiv
proapoptot
signal
sarscov
infect
induc
inhibit
tcellprim
abil
dc
compar
signific
upregul
inflammatori
chemokin
sarscovinfect
dc
show
low
express
antivir
cytokin
ifna
ifnb
ifnc
studi
accord
conclus
nprotein
sarscov
induc
ali
result
imbal
proinflammatori
antiinflammatori
cytokin
mani
inflammatori
antivir
gene
differenti
express
sar
patient
plenti
proinflammatori
cytokin
tnfa
significantli
increas
wherea
number
ifnstimul
gene
like
doublestrand
rnadepend
protein
kinas
interferoninduc
guanylatebind
cxc
motif
chemokin
decreas
acut
sever
case
like
sarscov
merscov
virus
unabl
significantli
stimul
express
antivir
cytokin
ifna
ifnb
induc
compar
level
tnfa
interact
might
potenti
mitochondri
apoptot
pathway
andor
enhanc
express
proapoptot
factor
tnfa
link
thymocyt
apoptosi
turn
reduc
express
antivir
cytokin
suggest
immun
paralysi
play
critic
role
mediat
pathogen
damag
sever
patient
infect
highli
pathogen
viru
like
evalu
effect
blockad
omci
potent
arthropodderiv
inhibitor
activ
bind
prevent
releas
complement
activ
use
treat
mice
infect
pandem
viru
omci
significantli
inhibit
neutrophil
macrophag
infiltr
airway
net
format
death
leukocyt
lung
epitheli
injuri
overal
lung
damag
studi
suggest
target
could
promis
approach
reduc
excess
inflammatori
reaction
associ
sever
form
iav
infect
found
express
upper
bronchial
lower
alveolar
airway
epitheli
cell
adenoviru
construct
sirna
use
silenc
mrna
lung
result
buildup
polymorphonuclear
leukocyt
lower
level
proinflammatori
mediat
bronchoalveolar
lavag
fluid
antagon
receptor
also
significantli
inhibit
develop
ard
induc
intraven
infus
cobra
venom
factor
includ
neutrophil
migrat
bronchoalveolar
vascular
leakag
blood
pressur
alter
proinflammatori
cytokin
includ
tnfa
level
bronchoalveolar
lavag
fluid
studi
indic
signal
greatli
contribut
inflamm
injuri
lung
target
treat
highli
pathogen
viru
infect
addit
intercept
signal
recent
shown
promis
benefici
effect
small
anim
model
aliard
reduc
proinflammatori
cytokin
polyclon
antibodi
led
significantli
reduc
inflamm
lung
allevi
ali
mice
studi
indic
inhibit
might
effect
clinic
intervent
ali
howev
studi
knockout
mice
demonstr
requir
protect
influenza
infect
proper
viral
clearanc
associ
chang
cellular
infiltr
data
accord
fact
complement
lead
mediat
overinflammatori
respons
induc
ali
wherea
lytic
membran
attack
complex
provid
protect
role
control
viral
infect
thu
develop
neutral
human
antihuman
antibodi
block
effect
affect
format
membran
attack
complex
vitro
experi
demonstr
novel
neutral
human
antihuman
antibodi
block
abil
induc
granulocyt
express
affect
abil
form
membran
attack
complex
african
green
monkey
inocul
viru
treat
intraven
antihuman
antibodi
treatment
monkey
substanti
attenu
ali
reduc
lung
infiltr
macrophag
neutrophil
level
inflammatori
mediat
data
suggest
human
antihuman
antibodi
might
provid
potenti
therapeut
reagent
patient
role
differ
viral
infect
effect
blockad
acut
lung
injuri
describ
tabl
neutral
human
antihuman
antibodi
would
potenti
therapeut
option
patient
complement
system
part
innat
immun
play
critic
role
host
defens
pathogen
unregul
complement
activ
like
play
crucial
role
pathogenesi
lung
diseas
complementactiv
product
display
power
biolog
activ
activ
phagocyt
cell
gener
oxid
releas
histon
cytokin
storm
particular
cytokin
storm
believ
respons
mani
death
influenza
pandem
sar
epidem
merscov
human
death
grow
awar
key
similar
contribut
cytokin
storm
manifest
lung
patholog
among
chronic
respiratori
diseas
caus
death
bleed
ebola
viru
key
trigger
induc
cytokin
storm
could
ideal
target
mani
lung
inflammatori
diseas
would
import
assess
therapeut
potenti
blockad
human
clinic
trial
evid
human
antibodi
greatli
reduc
lung
histopatholog
injuri
well
decreas
lung
infiltr
macrophag
neutrophil
level
proinflammatori
cytokin
includ
tnfa
monkey
model
ali
induc
herbicid
paraquat
shihui
sun
et
al
unpublish
data
thu
reason
specul
blockad
human
antihuman
antibodi
would
potenti
therapeut
target
highli
pathogen
viral
infectioninduc
acut
lung
injuri
ab
treatment
also
reduc
lung
injuri
neutrophil
infiltr
especi
day
viru
infect
also
ab
treatment
increas
surviv
rate
mortal
ab
group
compar
mortal
control
group
day
viru
challeng
hpai
viru
infect
murin
model
influenza
viru
infect
mice
increas
level
activ
byproduct
compar
mice
infect
either
season
pandem
influenza
virus
monkey
model
treatment
monkey
substanti
attenu
ali
markedli
reduc
lung
histopatholog
injuri
decreas
lung
infiltr
macrophag
neutrophil
moreov
treatment
decreas
intens
sir
bodi
temperatur
chang
minim
plasma
level
inflammatori
mediat
markedli
reduc
treatment
also
significantli
decreas
viru
titer
infect
lung
ab
antibodi
hpai
highli
pathogen
avian
influenza
sir
system
inflammatori
respons
syndrom
acut
lung
injuri
rx
wang
et
al
